BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 2, 2013
View Archived Issues
Lacer prepares new strontium salts for osteoporosis
Read More
New autotaxin inhibitors claimed by Bristol-Myers Squibb
Read More
Progen Pharmaceuticals signs license term sheet for PG-545
Read More
Special protocol assessment agreement reached for phase III AEZS-108 trial
Read More
Synergy Pharmaceuticals' GC-C agonist SP-333 completes phase I trial
Read More
Emergent BioSolutions acquires rights to pandemic influenza vaccine candidate
Read More
Phase IIb trial begins for plecanatide in IBS-C
Read More
Proteome Sciences' CKI-delta inhibitors improve cognition in Alzheimer's disease model
Read More
Targeting MALT1 as a therapeutic approach for ABC-DLBCL
Read More
AI-10-49 proves effective in murine leukemia model
Read More
In vivo profiling of mGlu5 receptor modulators
Read More
Hutchison MediPharma presents novel SYK inhibitors
Read More
Swiss researchers present new antibacterial prodrugs
Read More
New beta-amyloid ligands disclosed by Italian researchers
Read More
CT Atlantic and the Universitat Zurich patent novel antibodies for cancer
Read More
Affectis Pharmaceuticals synthesizes novel P2X7 receptor antagonists
Read More
New compound demonstrates efficacy in KSHV-associated primary effusion lymphoma
Read More
New hydrid cholinesterase inhibitors divulged by Polish team
Read More
Chugai Pharmaceutical develops novel bispecific antibody for hemophilia
Read More
Xoma to study gevokizumab for noninfectious anterior scleritis
Read More
FDA grants accelerated approval for Sirturo in tuberculosis
Read More
Data presented from phase Ib trial of a ghrelin receptor agonist for type 2 diabetes
Read More
Evotec and Apeiron Biologics establish cancer immunotherapy collaboration
Read More
Third milestone in Vernalis' drug discovery collaboration with Lundbeck
Read More
FDA approves Fulyzaq for diarrhea in patients with HIV/AIDS
Read More